Hualan Biological Engineering Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 640.65 million compared to CNY 623.38 million a year ago. Revenue was CNY 640.65 million compared to CNY 623.38 million a year ago. Net income was CNY 233.87 million compared to CNY 255.33 million a year ago. Basic earnings per share from continuing operations was CNY 0.1284 compared to CNY 0.1398 a year ago. Diluted earnings per share from continuing operations was CNY 0.1281 compared to CNY 0.1396 a year ago.